Calciphylaxis Market Research Report - Global Forecast till 2027

Calciphylaxis Market Information: By Diagnosis (Deep Skin Biopsies, Blood Tests and Imaging), Treatment, (Intensive Wound Care, Medication, Therapy, and Clot-Dissolving), End User (Hospitals, Clinics, Medical Research Centers) - Global Forecast till 2027

ID: MRFR/Pharma/2425-CR | | Region: Global | 152 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a syndrome associated with end-stage renal disease. The syndrome causes necrotic skin ulcers, which often leads to a fatal outcome. In 2008, Rogers and Coates stated that CUA is a rare but important cause of morbidity and mortality in patients with chronic kidney disease.  The prevalence of CUA is increasing in patients with renal failure, and the condition is also being recognized in non-uremic patients. Calciphylaxis affects up to 4% of dialysis patients, which starts with a calcification of small peripheral vessels that quickly becomes enlarged.


The market for calciphylaxis is growing at a swift pace. Increasing prevalence of end stage renal disease has spurred the growth of the market. According to the Regents of the University of California, over 650,000 patients every year in the United States and an estimated 2 million patients worldwide are affected by end stage renal disease (ESRD). Moreover, rising number of dialysis patients has spurred the growth of this market. According to the U.S. Renal Data System Annual Data Report, more than 660,000 Americans were under treatment for end stage renal disease out of which 468,000 were dialysis patients in 2016.


However, lack of treatment availability and high cost of the existing treatment may hamper the market growth during the forecast period.


The global calciphylaxis market is expected to grow at a CAGR of 10.70% during the forecast period 2017-2023. 


Intended Audience



  • Pharmaceutical Companies

  • Medical Devices Companies

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors 


Research Methodology Global Calciphylaxis Market


Source: World Health Organization, Centers for Disease Control and Prevention, expert interview market research future analysis, annual report, white paper, company presentation


Segmentation    


The global calciphylaxis market is segmented on the basis of diagnosis, treatment, and end user.


On the basis of the diagnosis, the calciphylaxis market is further segmented into deep skin biopsies, blood tests, imaging, and others. Deep skin biopsies is further segmented into shave biopsy, punch biopsy, and excisional biopsy. The blood tests is further segmented into serum parathormone levels, blood glucose levels, BUN (blood urea nitrogen), calcium levels, and others. Imaging is further segmented into magnetic resonance imaging (MRI), CT scan, ultrasound, and others.


 On the basis of the applications, the market is segmented into intensive wound care, medication, therapy, clot-dissolving, and others. Intensive wound care unit is further segmented into debridement, wet dressings, and others. Medication is further segmented into cinacalcet, sodium thiosulfate, steroids, and bisphosphonates.


On the basis of end user, it is segmented into hospitals, clinics, medical research centers, academic institutes, and others. 


Figure: Global Calciphylaxis Market, by Diagnosis, 2016 (%)


Global Calciphylaxis Market-


Source: World Health Organization, Centers for Disease Control and Prevention, expert interview market research future analysis, annual report, white paper, company presentation


 


Key Findings



  • Global calciphylaxis market is expected to reach around USD 3,722.6 million by 2023

  • Deep skin biopsies accounted for the largest market share in 2016 and which is projected grow at a CAGR of 10.35% during the forecast period from 2017-2023

  • Americas hold the largest share of the calciphylaxis market and is expected to reach USD 1,257.0 million by 2023

  • Asia Pacific is the fastest growing region across the globe and is expected to grow at a rate of CAGR 11.18% during the forecast period 


Regional Analysis The Americas dominate the global calciphylaxis market owing to the presence of strong economic condition, huge development in the healthcare domain, and focus of research institutions on updating technology for new and advanced diagnosis and treatment methods. Moreover, advanced hospitals infrastructures, and availability of skilled healthcare professional are further adding fuel to the growth of the market.   


Europe holds the second position in the market on the basis of increasing emphasis on rapid diagnosis and treatment of diseases, changing lifestyle, increasing prevalence of diseases among geriatric population. Asia Pacific is the fastest growing market owing to more number of developing nations present in this region, for instance, countries like India and China. These countries are encouraging the growth of the healthcare domain. Furthermore, increasing patient population from cancer in developing countries will directly increase the demand for various diagnosis & treatment methods, which, in turn, is likely to boost the growth of the market.    


The Middle East & Africa is expected to hold the least market share due to less availability of medical facilities, and less development in the healthcare domain. However, countries such as Qatar and Kuwait are focusing more on the healthcare domain and developing medical facilities, which is projected to boost the market of this region. 


Key Players                                                                                                         


Some of the key players in this market are Amgen Inc., Smith & Nephew plc, Medtronics, 3M, BSN Medical, ConvaTec Inc, Sanifit, and others.



1 Report Prologue

2 Market Introduction

2.1 Introduction 14

2.2 Scope of Study 14

2.3 Research Objective 15

2.4 Assumptions & Limitations 15

2.4.1 Assumptions 15

2.4.2 Limitations 15

2.5 Market Structure 16

3 Research Methodology: Calciphylaxis Market

3.1 Research Process 17

3.2 Market Size Estimation 19

3.2.1 Market Share analysis 20

3.3 Forecast Model 21

4 Market Dynamics

4.1 Drivers 22

4.1.1 Increasing patients population with renal failure 22

4.1.2 Increasing use of warfarin therapy 22

4.2 Restraints 23

4.2.1 Lack of treatment availability 23

4.2.2 Higher cost of existing treatment 23

4.3 Opportunities 23

4.3.1 Development of innovative drugs 23

4.3.2 Research and Development 23

4.4 Mega trends 24

4.4.1 Improved treatment for hyperparathyroidism 24

4.5 Macroeconomic indicators 24

4.6 Technology Trends & Assessment 25

4.6.1 Improvement in Novel therapies 25

5 Market Factor Analysis

5.1 Value Chain Analysis 26

5.1.1 R&D 26

5.1.2 Manufacturing 27

5.1.3 Distribution & Sales 27

5.1.4 Post-Sales Monitoring 27

5.3 Porter’s Five Forces Model 28

5.3.1 Bargaining Power of Suppliers 29

5.3.2 Bargaining Power of Buyers 29

5.3.3 Threat of New Entrants 29

5.3.4 Threat of Substitutes 29

5.3.5 Intensity of Rivalry 30

5.4 Pricing Analysis 30

5.5 Investment Opportunity Analysis 31

5.6 Merger and Acquisition Landscape 32

6 Calciphylaxis Market, By Diagnosis

6.1 Introduction 33

6.2 Deep Skin Biopsies 36

6.3 Blood Tests 36

6.4 Imaging 37

7 Calciphylaxis Market, By Treatment

7.1 Introduction 38

7.2 Intensive Wound Care 41

7.3 Medication 41

7.4 Therapy 42

7.5 Clot-dissolving 42

8 Calciphylaxis Market, By End User

8.1 Introduction 43

8.2 Hospitals 44

8.3 Clinics 45

8.4 Medical Research Centers 45

8.5 Academic institutes 46

9 Global Calciphylaxis Market, By Region

9.1 Introduction 47

9.2 Americas 49

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.2.1 U.S. 54

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.2.2 Canada 57

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.2.3 Latin America 60

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.3 Europe 63

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.3.1 Germany 68

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.3.2 France 71

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.3.3 UK 74

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.3.4 Italy 77

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.3.5 Spain 80

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.3.6 Eastern Europe 83

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.4 Asia Pacific 86

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.4.1 Japan 91

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.4.2 China 94

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.4.3 India 97

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.4.4 Australia 100

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.4.5 Republic of Korea 103

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.4.6 Rest of Asia Pacific 106

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.5 Middle East & Africa 109

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.5.1 UAE 114

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.5.2 Saudi Arabia 117

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.5.3 Egypt 120

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

9.5.4 Africa 123

Calciphylaxis Market, By Diagnosis

Calciphylaxis Market, By Treatment

Calciphylaxis Market, By End User

10 Competitive Landscape

10.1 Introduction 126

10.2 Company Share Analysis 127

11 Company Profile

11.1 Amgen Inc. 128

11.1.1 Overview 128

11.1.2 Product/Business Segment Overview 128

11.1.4 Financials 129

11.1.5 Key Developments 130

11.1.6 SWOT Analysis 130

11.2 Smith & Nephew plc 131

11.2.1 Company Overview 131

11.2.2 Product Overview 131

11.2.3 Financials 132

11.2.4 Key Developments 133

11.2.5 SWOT analysis 134

11.3 Medtronics 135

11.3.1 Company Overview 135

11.3.2 Product/Business Segment Overview 135

11.3.3 Financial Overview 135

11.3.4 Key Development 136

11.3.5 SWOT Analysis 137

11.4 3M 138

11.4.1 Company Overview 138

11.4.2 Product Overview 138

11.4.3 Financial Overview 138

11.5 Key Developments 140

11.5.1 SWOT Analysis 140

11.6 BSN Medical 141

11.6.1 Overview 141

11.6.2 Product Overview 141

11.6.3 Financials 141

11.6.4 Key Developments 142

11.6.5 SWOT Analysis 142

11.7 ConvaTec Inc. 143

11.7.1 Overview 143

11.7.2 Product Overview 143

11.7.3 Financials 144

11.7.4 Key Development 145

11.7.5 SWOT Analysis 145

11.8 Sanifit. 146

11.8.1 Overview 146

11.8.2 Product Overview 146

11.8.3 Financials 146

11.8.4 Key Development 146

11.8.5 SWOT Analysis 147

12 MRFR Conclusion

12.1 Key Findings 148

12.1.1 From CEO’s View Point 148

12.1.2 Unmet Needs 148

12.2 Key companies to watch 148

13 Appendix

13.1 Discussion Blue Print 149

13.2 References 151

14 List of Tables

TABLE 1 GLOBAL CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 34

TABLE 2 GLOBAL CALCIPHYLAXIS MARKET FOR DEEP SKIN BIOPSIES, BY REGION, 2020-2027 (USD MILLION) 36

TABLE 3 GLOBAL CALCIPHYLAXIS MARKET FOR BLOOD TESTS, BY REGION, 2020-2027 (USD MILLION) 36

TABLE 4 GLOBAL CALCIPHYLAXIS MARKET FOR IMAGING, BY REGION, 2020-2027 (USD MILLION) 37

TABLE 5 GLOBAL CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 39

TABLE 6 GLOBAL CALCIPHYLAXIS MARKET FOR INTENSIVE WOUND CARE, BY REGION, 2020-2027 (USD MILLION) 41

TABLE 7 GLOBAL CALCIPHYLAXIS MARKET FOR MEDICATION, BY REGION, 2020-2027 (USD MILLION) 41

TABLE 8 GLOBAL CALCIPHYLAXIS MARKET FOR THERAPY, BY REGION, 2020-2027 (USD MILLION) 42

TABLE 9 GLOBAL CALCIPHYLAXIS MARKET FOR CLOT-DISSOLVING, BY REGION, 2020-2027 (USD MILLION) 42

TABLE 10 GLOBAL CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 43

TABLE 11 GLOBAL CALCIPHYLAXIS MARKET FOR HOSPITALS, BY REGION, 2020-2027 (USD MILLION) 44

TABLE 12 GLOBAL CALCIPHYLAXIS MARKET FOR CLINICS, BY REGION, 2020-2027 (USD MILLION) 45

TABLE 13 GLOBAL CALCIPHYLAXIS MARKET FOR MEDICAL RESEARCH CENTERS, BY REGION, 2020-2027 (USD MILLION) 45

TABLE 14 GLOBAL CALCIPHYLAXIS MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2020-2027 (USD MILLION) 46

TABLE 15 GLOBAL CALCIPHYLAXIS MARKET, BY REGION, 2020-2027 (USD MILLION) 47

TABLE 16 AMERICAS CALCIPHYLAXIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 49

TABLE 17 AMERICAS CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 51

TABLE 18 AMERICAS CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 52

TABLE 19 AMERICAS CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 53

TABLE 20 U.S. CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 54

TABLE 21 U.S. CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 55

TABLE 22 U.S. CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 56

TABLE 23 CANADA CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 57

TABLE 24 CANADA CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 58

TABLE 25 CANADA CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 59

TABLE 26 LATIN AMERICA CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 60

TABLE 27 LATIN AMERICA CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 61

TABLE 28 LATIN AMERICA CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 62

TABLE 29 EUROPE CALCIPHYLAXIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 63

TABLE 30 EUROPE CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 65

TABLE 31 EUROPE CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 66

TABLE 32 EUROPE CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 67

TABLE 33 GERMANY CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 68

TABLE 34 GERMANY CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 69

TABLE 35 GERMANY CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 70

TABLE 36 FRANCE CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 71

TABLE 37 FRANCE CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 72

TABLE 38 FRANCE CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 73

TABLE 39 UK CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 74

TABLE 40 UK CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 75

TABLE 41 UK CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 76

TABLE 42 ITALY CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 77

TABLE 43 ITALY CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 78

TABLE 44 ITALY CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 79

TABLE 45 SPAIN CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 80

TABLE 46 SPAIN CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 81

TABLE 47 SPAIN CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 82

TABLE 48 EASTERN EUROPE CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 83

TABLE 49 EASTERN EUROPE CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 84

TABLE 50 EASTERN EUROPE CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 85

TABLE 51 ASIA PACIFIC CALCIPHYLAXIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 86

TABLE 52 ASIA PACIFIC CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 88

TABLE 53 ASIA PACIFIC CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 89

TABLE 54 ASIA PACIFIC CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 90

TABLE 55 JAPAN CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 91

TABLE 56 JAPAN CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 92

TABLE 57 JAPAN CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 93

TABLE 58 CHINA CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 94

TABLE 59 CHINA CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 95

TABLE 60 CHINA CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 96

TABLE 61 INDIA CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 97

TABLE 62 INDIA CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 98

TABLE 63 INDIA CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 99

TABLE 64 AUSTRALIA CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 100

TABLE 65 AUSTRALIA CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 101

TABLE 66 AUSTRALIA CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 102

TABLE 67 REPUBLIC OF KOREA CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 103

TABLE 68 REPUBLIC OF KOREA CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 104

TABLE 69 REPUBLIC OF KOREA CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 105

TABLE 70 REST OF ASIA PACIFIC CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 106

TABLE 71 REST OF ASIA PACIFIC CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 107

TABLE 72 REST OF ASIA PACIFIC CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 108

TABLE 73 MIDDLE EAST & AFRICA CALCIPHYLAXIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 109

TABLE 74 MIDDLE EAST & AFRICA CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 111

TABLE 75 MIDDLE EAST & AFRICA CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 112

TABLE 76 MIDDLE EAST & AFRICA CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 113

TABLE 77 UAE CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 114

TABLE 78 UAE CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 115

TABLE 79 UAE CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 116

TABLE 80 SAUDI ARABIA CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 117

TABLE 81 SAUDI ARABIA CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 118

TABLE 82 SAUDI ARABIA CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 119

TABLE 83 EGYPT CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 120

TABLE 84 EGYPT CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 121

TABLE 85 EGYPT CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 122

TABLE 86 AFRICA CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 123

TABLE 87 AFRICA CALCIPHYLAXIS MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 124

TABLE 88 AFRICA CALCIPHYLAXIS MARKET, BY END USER, 2020-2027 (USD MILLION) 125

TABLE 89 3M: KEY DEVELOPMENT 140

TABLE 90 BSN MEDICAL: KEY DEVELOPMENT 142

TABLE 91 CONVATEC INC.: KEY DEVELOPMENT 145

TABLE 92 SANIFIT: KEY DEVELOPMENT 146


15 List of Figures

FIGURE 1 GLOBAL CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020 (%) 12

FIGURE 2 GLOBAL CALCIPHYLAXIS MARKET, BY TREATMENT, 2020 (%) 12

FIGURE 3 GLOBAL CALCIPHYLAXIS MARKET, BY REGION, 2020 (%) 13

FIGURE 4 GLOBAL CALCIPHYLAXIS MARKET: MARKET STRUCTURE 16

FIGURE 5 RESEARCH PROCESS 17

FIGURE 6 MARKET ASSESMENT: TRAIGULATION APPROACH 18

FIGURE 7 GLOBAL CALCIPHYLAXIS MARKET: FORECAST MODEL 21

FIGURE 8 VALUE CHAIN: CALCIPHYLAXIS 26

FIGURE 9 PORTERS FIVE FORCES MODEL 28

FIGURE 10 GLOBAL CALCIPHYLAXIS MARKET, BY DIAGNOSIS, 2020 & 2027 (%) 35

FIGURE 11 GLOBAL CALCIPHYLAXIS MARKET, BY TREATMENT, 2020 & 2027 (%) 40

FIGURE 12 GLOBAL CALCIPHYLAXIS MARKET, BY END USER, 2020 & 2027 (%) 44

FIGURE 13 GLOBAL CALCIPHYLAXIS MARKET, BY REGION, 2020 & 2027 (USD MILLION) 48

FIGURE 14 AMERICAS CALCIPHYLAXIS MARKET, BY COUNTRY, 2020 (%) 50

FIGURE 15 EUROPE CALCIPHYLAXIS MARKET, BY COUNTRY, 2020 (%) 64

FIGURE 16 ASIA PACIFIC CALCIPHYLAXIS MARKET, BY COUNTRY, 2020 (%) 87

FIGURE 17 MIDDLE EAST & AFRICA CALCIPHYLAXIS MARKET, BY COUNTRY, 2020 (%) 110

FIGURE 18 GLOBAL CALCIPHYLAXIS MARKET: COMPETITIVE LANDSCAPE 126

FIGURE 19 GLOBAL CALCIPHYLAXIS MARKET: COMPANY SHARE ANALYSIS 127

FIGURE 20 AMGEN INC.: RECENT FINANCIALS 129

FIGURE 21 AMGEN INC.: GEOGRAPHICAL REVENUE 129

FIGURE 22 SMITH & NEPHEW PLC: RECENT FINANCIALS 132

FIGURE 23 SMITH & NEPHEW PLC: GEOGRAPHIC REVENUE MIX 132

FIGURE 24 SMITH & NEPHEW PLC: BUSINESS REVENUE MIX 133

FIGURE 25 MEDTRONICS: RECENT FINANCIAL 135

FIGURE 26 MEDTRONICS: GEOGRAPHICAL MIX 136

FIGURE 27 MEDTRONICS: OPERATING SEGMENTS 136

FIGURE 28 MEDTRONICS: SWOT ANALYSIS 137

FIGURE 29 3M: RECENT FINANCIAL 138

FIGURE 30 3M: OPERATING SEGMENTS 139

FIGURE 31 3M: GEOGRAPHIC SEGMENTS 139

FIGURE 32 3M: SWOT ANALYSIS 140

FIGURE 33 CONVATEC INC.: RECENT FINANCIAL 144

FIGURE 34 CONVATEC INC.: SEGMENTAL REVENUE 144